Talal El Zarif, MD

Talal El Zarif, MD, of Yale School of Medicine

Articles by Talal El Zarif, MD

Sequential Therapy Outcomes Following Recurrence After Adjuvant Pembrolizumab for RCC

Karl Semaan, MDAdvanced Renal Cell Carcinoma | June 5, 2024

Drs. Semaan and El Zarif detail an investigation into first-line systemic therapy following adjuvant immunotherapy for RCC.